Neoss® Group Opens Two New Sales Offices in Europe

Neoss® Group has announced the opening of two new sales organizations, Neoss Norden AB and Neoss UK & Ireland Ltd. These two organizations will ensure our continued growth and commercialization of our expanding product portfolio in the region. Most important, it will help us to better support dental professionals and their patients in Europe. Both organizations will begin operations December 1st, 2022.

“These two organizations are an important foundation to be able to support our growing customer base in Europe. Increasing our footprint in these markets is important to us, this is where it all started for Neoss. The Nordic region is particularly important due to it is where our implants are produced, our R&D is located and the dental implant heritage.”

Dr. Robert Gottlander, President and CEO of Neoss Group

As previously announced, Albin Wahlstrand will be the Managing Director for Neoss Norden AB. He brings over 20 years of experience within the dental industry and has worked with every aspect of the dental business including sales, product management, and business development.

Neoss Norden AB organization is located in the Biotech Center building next to the Institute of Odontology, University of Gothenburg. Neoss Norden AB, Arvid Wallgrens backe 20, 413 46 Göteborg, Sweden.

Fernando Spieler, current National Sales Manager will be promoted to Managing Director for the newly formed Neoss UK & Ireland Ltd. He has been part of the Neoss family for almost 2 years and before this has over 15 years of experience within the medical device industry.

Neoss UK & Ireland Ltd organization is in the same building as Neoss Ltd, Windsor House, Cornwall Rd, Harrogate HG1 2PW, United Kingdom.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.